title: Middle East and North Africa consensus on osteoporosis.
abstract: With the increasing life expectancy, osteoporosis is becoming a major worldwide health problem. The magnitude of the disease may become larger in developing countries, more particularly in the Middle East region where the prevalence of low bone mass is higher than in western countries. Although several local organizations and countries have developed guidelines for osteoporosis, no previous regional guidelines have been developed encompassing all Middle-Eastern and North African countries. The present document reviews all the regional published data on bone mineral density, risk factors, fracture prevalence and vitamin D status. It also gives simple recommendations applicable to all these countries. This document was endorsed by leading members of all the different regional countries including, Iran, Egypt, Tunisia, Jordan, Palestine, Syria, Iraq, Libya, Oman, Kuwait, Saudi Arabia and Bahrain.
authors.affiliation: Lebanese Osteoporosis Prevention Society, Shariati Hospital, Iran.
authors.forename: G
authors.initials: G
authors.lastname: Maalouf
authors.forename: M H
authors.initials: MH
authors.lastname: Gannagé-Yared
authors.forename: J
authors.initials: J
authors.lastname: Ezzedine
authors.forename: B
authors.initials: B
authors.lastname: Larijani
authors.forename: S
authors.initials: S
authors.lastname: Badawi
authors.forename: A
authors.initials: A
authors.lastname: Rached
authors.forename: L
authors.initials: L
authors.lastname: Zakroui
authors.forename: B
authors.initials: B
authors.lastname: Masri
authors.forename: E
authors.initials: E
authors.lastname: Azar
authors.forename: E
authors.initials: E
authors.lastname: Saba
authors.forename: R
authors.initials: R
authors.lastname: Nammari
authors.forename: G
authors.initials: G
authors.lastname: Adib
authors.forename: H
authors.initials: H
authors.lastname: Abou Samra
authors.forename: Z
authors.initials: Z
authors.lastname: Alrawi
authors.forename: S
authors.initials: S
authors.lastname: Salman
authors.forename: K
authors.initials: K
authors.lastname: El Muntasser
authors.forename: R
authors.initials: R
authors.lastname: Tarseen
authors.forename: W
authors.initials: W
authors.lastname: El Kharousi
authors.forename: M
authors.initials: M
authors.lastname: Al-Lamki
authors.forename: A N
authors.initials: AN
authors.lastname: Alothman
authors.forename: N
authors.initials: N
authors.lastname: Almarzook
authors.forename: M
authors.initials: M
authors.lastname: El Dessouki
authors.forename: R
authors.initials: R
authors.lastname: Sulaimani
authors.forename: J
authors.initials: J
authors.lastname: Saleh
authors.forename: A R
authors.initials: AR
authors.lastname: Suhaili
authors.forename: A
authors.initials: A
authors.lastname: Khan
authors.forename: P
authors.initials: P
authors.lastname: Delmas
authors.forename: E
authors.initials: E
authors.lastname: Seeman
mesh_terms: D000352:Africa, Northern / Q000453:epidemiology; D015519:Bone Density / Q000187:drug effects / Q000502:physiology*; D050071:Bone Density Conservation Agents / Q000494:pharmacology / Q000627:therapeutic use; D001842:Bone and Bones / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology*; D050723:Fractures, Bone / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D008877:Middle East / Q000453:epidemiology; D010024:Osteoporosis / Q000453:epidemiology* / Q000503:physiopathology* / Q000628:therapy; D012307:Risk Factors; D014808:Vitamin D Deficiency / Q000150:complications / Q000503:physiopathology / Q000517:prevention & control
chemical_list: D050071:Bone Density Conservation Agents